Michael Schaapveld

9.3k citations

158 papers · 5.8k · 2 hit papers · h-index 38

Impact in

Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment
Oncology top 1%
- Viral-associated cancers and disorders

Papers in

Oncology 43
- Cancer Treatment and Pharmacology 10
- Global Cancer Incidence and Screening 7
Cancer Research 34
- Breast Cancer Treatment Studies 29

Co-authors: Flora E. van Leeuwen (72 shared papers)Berthe M.P. Aleman (43 shared papers)Augustinus D. G. Krol (21 shared papers)Cécile P.M. Janus (22 shared papers)Elisabeth G.E. de Vries (17 shared papers)Frederika A. van Nimwegen (10 shared papers)R. Otter (15 shared papers)Michael Hauptmann (12 shared papers)
Journals: Journal of Clinical Oncology (23 papers)European Journal of Cancer (14 papers)Breast Cancer Research and Treatment (11 papers)British Journal of Cancer (10 papers)International Journal of Radiation Oncology*Biology*Physics (7 papers)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Michael Schaapveld

150 papers receiving 5.7k citations

Michael Schaapveld's Hit Papers

align trajectories log scale

Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma 2015 · 329 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Journal of Clinical Oncology
2015 JAMA Internal Medicine

Peers

Countries citing papers authored by Michael Schaapveld

Since Specialization

Citations

This map shows the geographic impact of Michael Schaapveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schaapveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schaapveld more than expected).

Fields of papers citing papers by Michael Schaapveld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Schaapveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schaapveld. The network helps show where Michael Schaapveld may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Schaapveld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Schaapveld Line = papers co-authored together Michael Schaapveld links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 158 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Cardiovascular Disease After Hodgkin Lymphoma Treatment JAMA Internal Medicine ·Frederika A. van Nimwegen, Michael Schaapveld, Cécile P.M. Janus, Augustinus D. G. Krol, Eefke Petersen, John Raemaekers, Wouter E.M. Kok, Berthe M.P. Aleman, Flora E. van Leeuwen Hit paper breakdown →	2015	366
2	Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma Journal of Clinical Oncology ·Frederika A. van Nimwegen, Michael Schaapveld, David J. Cutter, Cécile P.M. Janus, Augustinus D. G. Krol, Michael Hauptmann, Karen Kooijman, Judith M. Roesink, Richard van der Maazen, Sarah C. Darby, Berthe M.P. Aleman, Flora E. van Leeuwen Hit paper breakdown →	2015	329
3	Morbidity and mortality of inadvertent enterotomy during adhesiotomy British journal of surgery ·A A van der Krabben, Frederika Dijkstra, Marieke E. van de Nieuwenhuijzen, Michel M.P.J. Reijnen, Michael Schaapveld, Harry van Goor	2000	321
4	Long-Term Risk of Second Malignancy in Survivors of Hodgkin’s Disease Treated During Adolescence or Young Adulthood Journal of Clinical Oncology ·Flora E. van Leeuwen, Willem J. Klokman, Mars B. vanʼt Veer, Anton Hagenbeek, Augustinus D. G. Krol, Ursula A. O. Vetter, Michael Schaapveld, P. van Heerde, J. M. V. Burgers, R. Somers, Berthe M.P. Aleman	2000	303
5	Increased cancer risk after liver transplantation: a population-based study Journal of Hepatology ·Elizabeth B. Haagsma, Vincent E. Hagens, Michael Schaapveld, Aad P. van den Berg, Elisabeth G.E. de Vries, I. J. Klompmaker, Maarten J. H. Slooff, Peter L. M. Jansen	2001	257
6	Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma Cancer ·M.J.A. Engelen, Henrike E. Kos, Pax H.B. Willemse, Jan G. Aalders, Elisabeth G.E. de Vries, Michael Schaapveld, R. Otter, Ate G.J. van der Zee	2005	235
7	Thymic epithelial tumours: A population-based study of the incidence, diagnostic procedures and therapy European Journal of Cancer ·Wouter K. de Jong, J. L. G. Blaauwgeers, Michael Schaapveld, Wim Timens, Theo J. Klinkenberg, Harry J.M. Groen	2007	225
8	Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma JNCI Journal of the National Cancer Institute ·David J. Cutter, Michael Schaapveld, Sarah C. Darby, Michael Hauptmann, Frederika A. van Nimwegen, Augustinus D. G. Krol, Cécile P.M. Janus, Flora E. van Leeuwen, Berthe M.P. Aleman	2015	218
9	Risk of New Primary Nonbreast Cancers After Breast Cancer Treatment: A Dutch Population-Based Study Journal of Clinical Oncology ·Michael Schaapveld, Otto Visser, Marieke W.J. Louwman, Elisabeth G.E. de Vries, Pax H.B. Willemse, R. Otter, Winette T.A. van der Graaf, J.W.W. Coebergh, Flora E. van Leeuwen	2008	169
10	Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines Blood ·Frederika A. van Nimwegen, Georgios Ntentas, Sarah C. Darby, Michael Schaapveld, Michael Hauptmann, Pieternella J. Lugtenburg, Cécile P.M. Janus, Laurien Daniëls, Flora E. van Leeuwen, David J. Cutter, Berthe M.P. Aleman	2017	163
11	Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age Breast Cancer Research and Treatment ·Dorina M. van der Kolk, Geertruida H. de Bock, Beike Leegte, Michael Schaapveld, Marian J.E. Mourits, Jakob de Vries, Annemieke H. van der Hout, Jan C. Oosterwijk	2010	136
12	Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma The Lancet ·Arjan Diepstra, Marijke Niens, Edo Vellenga, GW van Imhoff, I Nolte, Michael Schaapveld, Gerrit van der Steege, Anke van den Berg, RE Kibbelaar, GJ te Meerman, S Poppema	2005	111
13	Determination of TP53 Mutation Is More Relevant Than Microsatellite Instability Status for the Prediction of Disease-Free Survival in Adjuvant-Treated Stage III Colon Cancer Patients Journal of Clinical Oncology ·Jantine L. Westra, Michael Schaapveld, Harry Hollema, Jelle P. de Boer, Marian M.J. Kraak, Debora de Jong, Arja ter Elst, Nanno H. Mulder, Charles H.C.M. Buys, Robert M.W. Hofstra, John Th. M. Plukker	2005	109
14	Increased colon cancer risk after severe Salmonella infection PLoS ONE ·Lapo Mughini‐Gras, Michael Schaapveld, J. H. Kramers, Sofie H. Mooij, Andra Neefjes‐Borst, Wilfrid van Pelt, Jacques Neefjes	2018	99
15	The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands Breast Cancer Research and Treatment ·Michael Schaapveld, Otto Visser, Marieke W.J. Louwman, Pax H.B. Willemse, Elisabeth G.E. de Vries, Winette T.A. van der Graaf, R. Otter, J.W.W. Coebergh, Flora E. van Leeuwen	2007	93
16	Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors International Journal of Radiation OncologyBiologyPhysics ·Naomi B. Boekel, Michael Schaapveld, Jourik A. Gietema, Nicola S. Russell, Philip Poortmans, Jacqueline Theuws, Dominic A.X. Schinagl, D. Rietveld, Michel I.M. Versteegh, Otto Visser, Emiel J. Rutgers, Berthe M.P. Aleman, Flora E. van Leeuwen	2015	92
17	HLA Class II Expression by Hodgkin Reed-Sternberg Cells Is an Independent Prognostic Factor in Classical Hodgkin's Lymphoma Journal of Clinical Oncology ·Arjan Diepstra, Gustaaf W. van Imhoff, Henrike E. Karim‐Kos, Anke van den Berg, Gerard J. te Meerman, Marijke Niens, Ilja M. Nolte, Esther Bastiaannet, Michael Schaapveld, Edo Vellenga, Sibrand Poppema	2007	89
18	Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors International Journal of Radiation OncologyBiologyPhysics ·Judy N. Jacobse, Frances Duane, Naomi B. Boekel, Michael Schaapveld, Michael Hauptmann, Maartje J. Hooning, Caroline Seynaeve, Margreet H.A. Baaijens, Jourik A. Gietema, Sarah C. Darby, Flora E. van Leeuwen, Berthe M.P. Aleman, Carolyn Taylor	2018	86
19	Risk of Diabetes Mellitus in Long-Term Survivors of Hodgkin Lymphoma Journal of Clinical Oncology ·Frederika A. van Nimwegen, Michael Schaapveld, Cécile P.M. Janus, Augustinus D. G. Krol, John Raemaekers, Leontien C.M. Kremer, Marilyn Stovall, Berthe M.P. Aleman, Flora E. van Leeuwen	2014	77
20	Latent Epstein-Barr Virus Infection of Tumor Cells in Classical Hodgkin's Lymphoma Predicts Adverse Outcome in Older Adult Patients Journal of Clinical Oncology ·Arjan Diepstra, Gustaaf W. van Imhoff, Michael Schaapveld, Henrike E. Karim‐Kos, Anke van den Berg, Edo Vellenga, Sibrand Poppema	2009	68

About Michael Schaapveld

Michael Schaapveld is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Surgery and Cardiology and Cardiovascular Medicine, having authored 158 papers that have together received 5.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (29 papers), Lymphoma Diagnosis and Treatment (20 papers), Chemotherapy-induced cardiotoxicity and mitigation (18 papers), Multiple and Secondary Primary Cancers (14 papers), Cancer Treatment and Pharmacology (10 papers), Testicular diseases and treatments (9 papers), BRCA gene mutations in cancer (8 papers) and Global Cancer Incidence and Screening (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (994 citations), Oncology (1.4k citations), Cancer Research (751 citations), Cardiology and Cardiovascular Medicine (870 citations) and Reproductive Medicine (272 citations). Michael Schaapveld has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Flora E. van Leeuwen, Berthe M.P. Aleman, Augustinus D. G. Krol, Cécile P.M. Janus, Elisabeth G.E. de Vries, Frederika A. van Nimwegen, R. Otter, Michael Hauptmann, Sarah C. Darby and Pax H.B. Willemse. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Breast Cancer Research and Treatment, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Michael Schaapveld

Impact in

Papers in i

In The Last Decade

Michael Schaapveld

Michael Schaapveld's Hit Papers

Peers

Countries citing papers authored by Michael Schaapveld

Fields of papers citing papers by Michael Schaapveld

All Works

About Michael Schaapveld

Explore authors with similar magnitude of impact

Papers in